FDA Drug recall D-1326-2020
Sterile Cannabidiol (CBD) 4mg/mL, 10mL vial
- FDA Drug
- Class II
- terminated
- Published 2020-07-01
On 2020-07-01 the FDA classified a Class II recall of Sterile Cannabidiol (CBD) 4mg/mL, 10mL vial by Biota Biosciences, citing lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1326-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-05-11 |
| Published | 2020-07-01 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Biota Biosciences |
| Distribution | US |
Product
Sterile Cannabidiol (CBD) 4mg/mL, 10mL vial
Reason
Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin
Identifiers
| code_info | Lot #: 2H071219P, 2H0712019P, 2H07122019P, Exp. Date 7/12/2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1326-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.